Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:00:36 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Q:CELZ - CREATIVE MEDICAL TECH HOLDING INC - https://www.creativemedicaltechnology.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CELZ - Q0.12.70·3.010.12.77+0.155.769.41782142.64  2.805  2.616.90  1.7419:39:47Jul 1715 min RT 2¢

Recent Trades - Last 10 of 214
Time ETExPriceChangeVolume
19:39:47Q2.700.0811
19:39:23Q2.730.115
19:39:23Q2.730.1110
19:29:55Q2.730.115
18:04:13Q2.770.152
18:04:13Q2.730.118
17:39:51Q2.770.1526
17:36:07Q2.800.1850
16:54:27Q2.770.153
16:04:06Q2.770.151

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-17 09:15U:CELZNews ReleaseCreative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
2025-07-11 08:01U:CELZNews ReleaseCreative Medical Technology Holdings Receives Notice of Allowance for ImmCelz(TM) for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling
2025-03-20 07:50U:CELZNews ReleaseCreative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
2025-03-06 08:10U:CELZNews ReleaseCreative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
2025-02-20 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem(TM) Program's Success and Growth Potential
2025-02-14 07:01U:CELZNews ReleaseCreative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine(TM) Procedure using AlloStem(TM)
2025-02-11 09:25U:CELZNews ReleaseCreative Medical Technology Reports Positive One-Year Results for AlloStem(TM) Type 2 Diabetes Program
2025-02-05 08:25U:CELZNews ReleaseCreative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
2025-01-30 09:25U:CELZNews ReleaseCreative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
2024-11-13 09:00U:CELZNews ReleaseCreative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
2024-10-23 08:00U:CELZNews ReleaseCreative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2024-07-24 09:01U:CELZNews ReleaseCreative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program